1179 related articles for article (PubMed ID: 28176888)
1. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
4. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
6. The natural history of community-acquired pneumonia in COPD patients: a population database analysis.
Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA
Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820
[TBL] [Abstract][Full Text] [Related]
7. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
8. Impact of COPD on outcomes in hospitalized patients with community-acquired pneumonia: Analysis of the Spanish national hospital discharge database (2004-2013).
de Miguel-Díez J; López-de-Andrés A; Hernández-Barrera V; Jiménez-Trujillo I; Méndez-Bailón M; de Miguel-Yanes JM; Jiménez-García R
Eur J Intern Med; 2017 Sep; 43():69-76. PubMed ID: 28615117
[TBL] [Abstract][Full Text] [Related]
9. Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.
Braeken DC; Rohde GG; Franssen FM; Driessen JH; van Staa TP; Souverein PC; Wouters EF; de Vries F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2425-2432. PubMed ID: 28860737
[TBL] [Abstract][Full Text] [Related]
10. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
[TBL] [Abstract][Full Text] [Related]
11. Hospitalisation with community-acquired pneumonia among patients with type 2 diabetes: an observational population-based study in Spain from 2004 to 2013.
López-de-Andrés A; de Miguel-Díez J; Jiménez-Trujillo I; Hernández-Barrera V; de Miguel-Yanes JM; Méndez-Bailón M; Pérez-Farinós N; Salinero-Fort MÁ; Jiménez-García R
BMJ Open; 2017 Jan; 7(1):e013097. PubMed ID: 28057653
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.
Cilli A; Erdem H; Karakurt Z; Turkan H; Yazicioglu-Mocin O; Adiguzel N; Gungor G; Bilge U; Tasci C; Yilmaz G; Oncul O; Dogan-Celik A; Erdemli O; Oztoprak N; Samur AA; Tomak Y; Inan A; Karaboga B; Tok D; Temur S; Oksuz H; Senturk O; Buyukkocak U; Yilmaz-Karadag F; Ozcengiz D; Karakas A; Savasci U; Ozgen-Alpaydın A; Kilic E; Elaldi N; Bilgic H
J Crit Care; 2013 Dec; 28(6):975-9. PubMed ID: 24075301
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
[TBL] [Abstract][Full Text] [Related]
17. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease.
Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Sasabuchi Y; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2017; 12():1605-1611. PubMed ID: 28615933
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
Yamauchi Y; Yasunaga H; Matsui H; Hasegawa W; Jo T; Takami K; Fushimi K; Nagase T
BMC Pulm Med; 2015 Jul; 15():69. PubMed ID: 26152178
[TBL] [Abstract][Full Text] [Related]
19. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
20. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
